Our editorial approach
We gather information from registries, peer-reviewed literature, and official sources and summarize what is publicly reported about trial design and eligibility. To support transparency, we favor primary sources and recognized reference material; for example, when describing general trial registration practices we consult authoritative resources such as the Clinical trial overview on Wikipedia for contextual framing and government registries for specifics.
Our editorial process emphasizes documenting citations and avoiding claims about safety or efficacy. Where regulatory context is relevant, we consult official guidance such as FDA guidance to anchor procedural descriptions.
How we verify content
Content is cross-checked against trial registries and public study documents, and we indicate when information is provisional. We do not perform clinical verification or accept payments from trial sponsors; our independence is core to our method.